Skip to main content
Screener/Healthcare/Biotechnology

OCUL — Ocular Therapeutix, Inc.

NASDAQ
$10.10-0.10 (-1.03%)
Mid CapUnder $20Healthcare
$6.23
$16.44
$10.09
$10.32
EPS (TTM)$-1.46
P/E Ratio-7.81
Dividend Yield—
Market Cap$2.35B
Volume1.21M
Prev Close$10.19
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$10.8M-$88.6M$-0.4087.7%-821.6%
Q4 '25$13.3M-$64.7M$-0.2988.0%-488.0%
Q3 '25$14.5M-$69.4M$-0.3887.8%-477.3%
Q2 '25$13.5M-$67.8M$-0.3985.6%-503.9%
Q1 '25$10.7M-$64.1M$-0.3888.2%-598.7%
Q4 '24$17.1M-$48.4M$-0.2992.8%-283.3%
Q3 '24$15.4M-$36.5M$-0.2289.9%-236.6%
Q2 '24$16.4M-$43.8M$-0.2690.8%-266.3%
Get Your Daily Market Recap